Production of IgG Fusion Proteins Transiently Expressed in Nicotiana benthamiana
January 16th, 2021
7.2K views
We describe here a simple method for expression, extraction, and purification of recombinant human IgG fused to GFP in Nicotiana benthamiana. This protocol can be extended to purification and visualization of numerous proteins that utilize column chromatography. Moreover, the protocol is adaptable to the in-person and virtual college teaching laboratory, providing project-based exploration.
Overview
This study presents a simple method for the expression, extraction, and purification of recombinant human IgG fused to GFP using the Nicotiana benthamiana plant model. The protocol allows for the visualization of plant-produced antibodies through column chromatography and is designed for both in-person and virtual college laboratory settings.
Key Study Components
Research Area
- Protein purification
- Transgenic plants
- Recombinant protein expression
Background
- Importance of recombinant proteins in research.
- Applicability of GFP as a visualization tool.
- Role of Nicotiana benthamiana in biotechnological applications.
Methods Used
- Column chromatography for protein purification
- Nicotiana benthamiana as the biological system
- GFP tagging for protein visualization
Main Results
- Successful expression of recombinant IgG fused to GFP.
- Visualization of protein throughout the purification process.
- Demonstrated method's effectiveness in laboratory settings.
Conclusions
- The protocol provides a reliable method for protein expression and purification in plant systems.
- This approach has significant implications for both academic research and practical applications in biotechnology.
Frequently Asked Questions
What is the main application of the described protocol?
The protocol is used for the expression, purification, and visualization of recombinant proteins in Nicotiana benthamiana.
Can this method be adapted for teaching purposes?
Yes, it is designed for both in-person and virtual college laboratory teaching.
What role does GFP play in this study?
GFP serves as a tag for visualizing recombinant proteins during the purification process.
Which plant is utilized in this protocol?
The Nicotiana benthamiana plant is used for protein expression.
Is this method limited to IgG proteins?
No, it can be extended to various proteins that can be purified via column chromatography.
What temperature conditions are required for growing the plants?
The plants should be kept at 23 to 25 degrees Celsius with a 16-hour photoperiod.
What are the main steps in the purification process?
The main steps include infiltration of Agrobacterium, expression of the protein, and purification using column chromatography.
Executive Industry Relevance
Plant-based expression systems offer a scalable, low-cost alternative for recombinant antibody production, addressing manufacturing bottlenecks in biologics development. This method enables rapid, milligram-scale production of IgG fusion proteins in Nicotiana benthamiana using transient expression, supporting early-stage target validation and lead identification. The GFP-tagged design allows real-time visualization of expression and purification, enhancing process monitoring and reducing attrition in discovery workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables rapid production and visualization of IgG fusion proteins to interrogate therapeutic hypotheses and assess target engagement.
- Operational Value: Supports functional target validation through observable GFP fluorescence during expression in planta.
- Predictive Value: Facilitates preclinical de-risking by allowing early assessment of protein stability, folding, and post-translational modifications in a eukaryotic system.
Screening & Assay Development
- Assay Readiness: Produces purified, GFP-tagged antibody fusions suitable for use as positive controls or detection reagents in downstream screening assays.
- Reproducibility: Standardized infiltration and purification steps yield consistent protein quantities and quality across experiments.
- Scalability: Single-researcher execution using few plants enables parallel testing of multiple constructs for lead identification campaigns.
Translational & Preclinical Research
- Translational Continuity: The system produces antibodies with mammalian-like folding and post-translational modifications, supporting relevance to human biologics.
- Preclinical Modeling: Purified IgG-GFP fusions can be used to study biodistribution, target binding, and effector functions in disease-relevant models.
- Risk-Adjusted Advancement: Early visualization of expression and purification outcomes enables go/no-go decisions based on yield and integrity data.
Pipeline & Workflow Integration
This method fits within the discovery continuum from target validation through lead identification to preclinical evaluation, providing a visible, quantifiable output at each stage.
- Discovery Biology: Enables hypothesis testing via rapid expression and visualization of antibody constructs in a living system.
- Screening: Generates standardized, fluorescently labeled protein batches for use in binding, neutralization, or cellular assays.
- Analytics: Fluorescence and absorbance measurements at 280 nm allow quantification and purity assessment of eluted fractions.
- Translational Research: Supports continuity to preclinical work by producing antibodies with proper assembly and modification profiles.
- Enterprise Reuse: The platform can be reused across multiple projects for rapid prototyping of antibody fusions, reducing dependency on mammalian cell culture for early material.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation through observable expression and purification trajectories.
- Operational Value: Enables standardization, reproducibility, and low-resource protein production without specialized fermentation infrastructure.
- Strategic Value: Reduces biological risk early in the pipeline by providing early insights into protein behavior and yield.
- Portfolio Impact: Supports risk-adjusted prioritization by delivering quantifiable, visual data on expression success and protein integrity.
Implementation Considerations
- Requires expertise in molecular cloning, agroinfiltration, and basic protein purification techniques.
- Depends on access to growth chambers, centrifugation equipment, and chromatography systems.
- Necessitates standardization of infiltration timing, leaf harvesting, and buffer conditions across users and labs.
- Adaptation to different antibody formats or fusion partners may require optimization of infiltration ratios and elution conditions.
- Practical limitations include variability in infiltration efficiency and the need for protease inhibitors to prevent degradation, as noted in observed 10 kDa bands.
Biopharma FAQs
Why does GFP fluorescence monitoring matter for target validation in this IgG fusion expression system?
GFP fluorescence allows real-time visualization of expression levels and subcellular localization during the transient expression phase in N. benthamiana leaves. This enables researchers to correlate fluorescence intensity with protein yield and assess construct functionality early in the discovery process. Monitoring fluorescence over time supports go/no-go decisions based on expression kinetics and stability.
How does independent variable isolation (e.g., construct design, infiltration timing) impact discovery pipeline outcomes in this plant-based expression method?
Isolating variables such as GFP variant (native vs. acid-stable), antibody construct, and infiltration timing enables precise assessment of their individual effects on expression yield and protein stability. This approach supports mechanistic de-risking by identifying which factors most significantly influence functional protein production. Controlling these variables improves reproducibility and data interpretation in lead identification efforts.
What quantitative dependent variable measurements enable assessment of protein purification success in this protocol?
Antibody concentration is determined by measuring absorbance at 280 nm using a spectrophotometer, providing a quantitative readout of purified yield. Fluorescence intensity of eluted fractions, particularly peak signal in the second elution fraction, serves as a dependent variable for assessing GFP-tagged IgG recovery. These measurements allow comparison across constructs and purification runs to evaluate process efficiency.
Why do replication requirements (e.g., multiple plants per construct, repeated experiments) matter for cross-functional collaboration in this expression system?
Using multiple plants per construct and repeating experiments ensures statistical reliability of expression and purification results, reducing variability due to biological noise. Consistent replication enables teams to compare data across projects and sites with confidence in the robustness of the expression platform. This supports alignment between discovery, assay development, and preclinical teams relying on reproducible material supply.
What statistical analysis capabilities are required before implementing this IgG-GFP expression and purification method in a discovery workflow?
Basic statistical analysis of fluorescence intensity, yield (mg/g leaf weight), and purity ratios across replicates is needed to assess expression consistency and purification efficiency. Comparing means and variances between experimental groups (e.g., different GFP fusions or infiltration conditions) helps identify significant improvements. These analyses support data-driven decisions in target validation and lead selection without requiring advanced biostatistical infrastructure.
Chapters in this video
0:00
Introduction
0:38
Cultivate Nicotiana benthamiana Plants
1:53
Preparation of Agrobacterium tumefaciens for Infiltration
3:51
Transient Needle-less Agroinfiltration
5:24
Grow and Observe the Infiltrated N.benthamiana
6:10
Protein Extraction
7:56
Protein G Column Chromatography
11:23
Representative Results
12:56
Conclusion
